" class="no-js "lang="en-US"> CVS Health Names Tilak Mandadi Executive Vice President and Chief Data, Digital and Technology Officer - Medtech Alert
Tuesday, December 03, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
CVS Health Names Tilak Mandadi Executive Vice President and Chief Data

July 11 2022

CVS Health Names Tilak Mandadi Executive Vice President and Chief Data, Digital and Technology Officer

CVS Health (NYSE: CVS) has appointed Tilak Mandadi as Executive Vice President and to the newly created role of Chief Data, Digital and Technology Officer, effective July 25. Mandadi will be responsible for the company’s data, digital and technology strategy while overseeing growth and innovation through digital-led, consumer-focused experiences and services.

“Technology is a catalyst for value-creation and growth at CVS Health,” said CVS Health President and CEO Karen S. Lynch. “It is crucial that we continue to enhance customer engagement and experiences, and we’re confident Tilak will drive these efforts as we prioritize serving consumers wherever and whenever they need health care.”

Mandadi joins CVS Health from MGM Resorts International where he served as Chief Strategy, Innovation & Technology Officer. Prior to that, he served in senior digital strategy roles for Disney Parks, Experiences and Products, and American Express.

“CVS Health serves more than 44 million unique digital customers and is increasingly integrating digital solutions into the consumer health care experience,” said Mandadi. “I look forward to helping make health care more seamless, convenient, and personalized, and driving business agility and growth through technology, data, digital and experiential innovations.”

Mandadi will become a member of the company’s executive leadership team and will report directly to Lynch. He holds a master’s degree in computer science from the University of Oregon.

People In This Post

Karen S. Lynch

Karen S. Lynch
Tilak Mandadi

Tilak Mandadi

Companies In This Post

CVS Health | Pharmtech Focus

CVS Health
  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more
More On